It can interact with several common medications including those for blood pressure, diabetes, and blood thinners and shouldn't be taken in pregnancy
Furthermore, Ectopic lipid deposition or inflammation in the endocrine pancreas, could potentially influence GIP receptor expression
Timing may influence risk
Viking Therapeutics Sector: Dual and triple agonists for obesity, metabolic, and liver disease HQ: San Diego, CA Year Founded: 2012 Origin Story: The company built its pipeline around small molecule and peptide candidates licensed from academic and pharma sources, eventually advancing VK2735, a dual GLP-1/GIP receptor agonist designed to be the first such therapy available in both oral and injectable formulations
Am J Clin Nutr 2009
Thus, the GLP-1 WT albiglutide-mimic demonstrated in vivo functionality and glucose-lowering properties on par with those of Tanzeum